New Study on Type 1 Diabetes: Type 1 diabetes is an autumn disease in which the patient’s body stops producing insulin. Due to this blood sugar levels. When insulin does not produce in the body, the body begins to break the fat for energy. This is a dangerous level of diabetes and kitosid levels in the blood, called Diabetes Kotasidosis (DKA). This is a serious condition and it is treated with insulin. Now a new research reveals that not only insulin but also a significant role in this process.
Published in the Journal of Clinical Investigation
the study It shows that Laptron Hormone is born by our body’s fat cells and it controls the hypothemums of the brain and controls the balance of appetite and energy. When there is a lack of insulin, there is also the level of laptin in the blood. It indicates the brain that the body lacks energy in the body while the body is present in glucose and fat. The brain reactions on this sign and increases the production of diabetes and kitonus, which is the case of diabetes kito acidosis.
In 2011, Professor of the Washington University of the United States. Michael Schwartz and his team in vaccinated laptin in the brain of type 1 diabetes and rats. Initially, it did not have a special impact, but after 4 days, scientists were amazed because glucose and kitone level in the blood of the animals became normal without insulin. Not only reduced the sugar level, but also in this balance. It was indicated that the brain itself can control blood sugar.
This search is now supporting the support of scientists. When the research appeared in 2011, the scientific community did not take it seriously. Now, years, the published new studies and analysis are strengthened the fact that the brain can play a big role in Type 1 diabetes. Dr. Shamets are now planning to take permission for human trials from the US FDA, so that the laptin can show the effect in humans.
Insulin, 104 years ago, the research was a historic achievement, but this new search can be the next step. If the diabetes can be controlled by Laptin, patients can be freed from monitoring of insulin injection and blood sugar daily. According to this new research, if the brain can be convinced that the body can be interrupted or preventing the production of glucose and kitonus production, DKA can be stopped. This understanding challenges traditional thinking that type 1 sugar is due to lack of insulin.